THERESA HENDERSON: Open Payments
NPI 1013583012 · WHITLEY CITY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 26 payments from 11 companies in 2025. Trend: 2023 $76 · 2024 $291 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $150 |
| Supernus Pharmaceuticals, Inc. | 4 | $118 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, Qelbree, FANAPT, QULIPTA, CAPLYTA, Jornay PM, AIRSUPRA, ZEPBOUND.
Industry payments across KY — which companies pay providers there.
